logo
Smart Dialysis Ecosystems: Next Generation Precision Care Using AI

Smart Dialysis Ecosystems: Next Generation Precision Care Using AI

Time of India16 hours ago
India is facing a silent yet significant kidney care crisis. With over 220,000 new end-stage renal disease (ESRD) patients added every year, the need for 34 million dialysis treatments is created, and the supply-demand gap continues to widen.
Today, the country has barely 50,000 dialysis machines to serve a population that requires more than double that number. Almost 60% of patients are forced to travel more than 50 km per session, resulting in dropouts, delayed treatment, and potentially avoidable complications.
What India needs is not only a greater number of such centers, but also smarter and interconnected dialysis ecosystems enhanced by the power of artificial intelligence, machine learning, and IoT. These new-age technologies are establishing the foundation of
precision care in nephrology
.
The Artificial Intelligence Revolution in Kidney Care
Predictive analytics is the driving force of this evolution. Artificial intelligence models can currently process real-time data on blood pressure trends, fluid levels, and treatment history to predict complications like intradialytic hypotension with more than 90% accuracy. Such proactive monitoring reduces the need for emergency interventions and enhances patient safety on a larger scale.
What's more, personalized treatment plans, once an elite hospital's privilege, are becoming scalable. Adjusting the duration of dialysis, rates of fluid removal, and doses of medication according to individual patient profiles gives rise to the concept of machine learning. This results in significantly better outcomes, 20 to 30% better, and allows patients to lead more complete lives despite living with a chronic disease.
Reducing the Urban-Rural Divide With Remote Monitoring
The fact on the ground is plain: most dialysis centres are based in the cities. But now, with monitoring-capable dialysis machines and the Internet of Things, nephrologists can remotely monitor sessions at rural and semi-urban centres. This both enhances quality control and saves on patient travel time and dropout rates.
Operationally, Artificial Intelligence is increasing efficiency as well, through automated scheduling, inventory management, and predictive maintenance for machines. These advancements result in reduced costs, decreased absence of usage sessions, and greater dependability—all key factors in a resource-limited healthcare environment.
Creating an Ecosystem: Policy, Partnerships and Purpose
It's crucial that dialysis care doesn't progress in isolated silos. Public-private partnerships (PPPs) like the ones envisioned by the Pradhan Mantri National Dialysis Program are essential for scaling up smart dialysis solutions. The Indian government has emphasized indigenous manufacturing and digital health, paving the way for Artificial Intelligence to become a mainstream part of healthcare delivery.
Sustainability is another key benefit. Smart dialysis centres are more conservative about water and power use, and they are less wasteful in their approach. Predictive tools help prevent machine downtime, making it viable even in the most remote or under-resourced parts of the country.
A Glimpse into the Future
Artificial Intelligence is not the end; it's the beginning and the enabler behind achieving quality dialysis equity for all. As we now move into the age of 3D-printed organs, AI-augmented artificial kidneys, and real-time biomarker monitoring, our vision at NephroPlus extends beyond treatment.
Our zero-cost Hepatitis C elimination program across Bihar and Andhra Pradesh has screened and treated hundreds of dialysis patients, showcasing the power of data-driven, integrated, and patient-first care.
On top of that, NephroPlus uses data-driven insights to enhance patient care by spotting trends and refining treatment plans. This enables us to tailor our services to meet each patient's unique needs more effectively.
India is well-positioned to become the global leader in smart dialysis care, not by emulating the Western model but by creating smart, scalable, and sustainable systems that fit our ground realities.
This article is written by Vikram Vuppala Founder and CEO, NephroPlus
Disclaimer - The above content is non-editorial, and ET Healthworld hereby disclaims any and all warranties, expressed or implied, relating to it, and does not guarantee, vouch for or necessarily endorse any of the content.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Consumer health cos woo Gen Z with chewables
Consumer health cos woo Gen Z with chewables

Time of India

time40 minutes ago

  • Time of India

Consumer health cos woo Gen Z with chewables

NEW DELHI: Gen Z's preference for trendy, convenient, and non-pill OTC formats such as gummies, chewables and effervescent powders, combined with rising health awareness, is fuelling significant growth in India's consumer healthcare market. The trend is driving strong investments in innovation as companies including Haleon India, Dabur and Rasna seek to capitalise on emerging consumer trends and diverse cohorts. Despite sluggish demand, companies continue to invest steadily in innovation - both organically and through acquisitions - being aware that returns typically require a longer-term horizon. For some, like Haleon India (formerly GlaxoSmithKline Consumer Healthcare), this strategy is already paying off. The company achieved a high single-digit revenue growth in the quarter ended March 2025, outperforming other Asia-Pacific markets, including China. The UK-based giant, with revenues exceeding over $14.3 billion, plans to democratise healthcare in India - where high costs remain a barrier - by focusing on small, affordable packs of its leading brands tailored for value-conscious consumers, according to Navneet Saluja, general manager, Indian sub-continent, Haleon. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 2025 Top Trending local enterprise accounting software [Click Here] Esseps Learn More Undo Innovative formats like gummies, effervescent tablets, chewables, and liquid drops are gaining traction, driven by direct-to-consumer brands in India's over Rs 40,000 crore consumer healthcare market. This mirrors global trends, where convenience, palatability, and visual appeal are key factors shaping consumer preferences. Homegrown FMCG company Dabur has undertaken a comprehensive refresh of its 'Vision' strategy to achieve a sustainable double-digit CAGR by FY28 in both topline and bottomline. Says Dabur India CEO Mohit Malhotra: "Premiumisation and contemporisation across categories is a key pillar of this strategy. Some categories that we will be looking at include, gummies, powders and effervescent in the healthcare business. In addition, we have been increasing the relevance of our time-tested and efficacious products by introducing new age formats". And, to cater to health-conscious Gen Z, Rasna, a mass-market beverage brand, recently acquired ready-to-drink (RTD) brand Jumpin from Hershey's India. Piruz Khambatta, group chairman of Rasna says the company plans to tap into India's booming non-carbonated RTD market, with a vitamin-fortified fruit juice beverage that has low sugar content. These moves reflect a broader trend: The demand for convenient, on-the-go product options is rapidly expanding, unlocking strong growth potential in India. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now

27 of Kol's 1st 38 heart recipients survived follow-up period: Study
27 of Kol's 1st 38 heart recipients survived follow-up period: Study

Time of India

time3 hours ago

  • Time of India

27 of Kol's 1st 38 heart recipients survived follow-up period: Study

1 2 3 Kolkata: In a first-of-its-kind initiative, a group of doctors conducted a follow-up on 38 heart recipients, who underwent transplantation of the organ in Kolkata between 2018 and 2023. The survey conducted by these doctors show that 27 of these 38 patients, who underwent heart transplantation till Oct, 2023, were alive at the time of the follow-up. The data was collected from seven participating hospitals, where the transplants took place. The patients were in the age group of 12 to 58 years, 28 (73.6%) recipients being male and 10 (23.4%) female. Three were paediatric. According to the survey, out of the 38 heart transplant cases, 33 recipients were discharged from the hospitals where they underwent the surgeries. During the follow-up period, five patients died due to infective complications and one passed away because of organ rejection. Heart transplantation made its debut in Bengal only in May, 2018, at a private hospital. You Can Also Check: Kolkata AQI | Weather in Kolkata | Bank Holidays in Kolkata | Public Holidays in Kolkata Data compiled shows a 30-day mortality rate of 13.2%, with five out of the 38 recipients attributed to low cardiac output syndrome, possibly stemming from post-operative primary graft dysfunction (PGD.) Infective complications were noted in 11 recipients (28.9%). The article titled 'Heart Transplant in West Bengal: Insights from a Collective Experience of Multiple Centers in an Indian State', published in the Indian Journal of Transplantation, also pointed out challenges such as postoperative primary graft dysfunction (PGD) and infections, which can be addressed with continued efforts, gaining further experience, and infrastructure development. Doctors Debasis Das, Nilanjan Dutta, Shubhadeep Das of Narayana Superspeciality Hospital, Howrah, Pradeep Narayan, Ayan Kar, Mrinalendu Das, Lalit Kapoor of RN Tagore Hospital, Kunal Sarkar and Soumyajit Ghosh of Medica Superspeciality Hospital, Subhendu Sekhar Mahapatra of IPGMER, Plaban Mukherjee and Subrata Dey of Medical College Kolkata, Tamashis Mukherjee of Apollo, along with Kayapanda Mandana and Tapas RayChaudhury of Fortis, came together to piece together the data. The first successful heart transplant from a brain-dead donor in India was conducted in 1994 at AIIMS, followed shortly by Madras Medical Mission Hospital, Chennai. "Despite the delayed start in West Bengal, the programme has witnessed significant growth. Currently, West Bengal has seven accredited centres for heart transplantation," said the authors. Among the seven hospitals with heart transplant facilities in the state, two are state-run facilities where the procedure is done for free. "This development marks a milestone in the region's healthcare, providing hope to patients with end-stage heart failure. Challenges such as postoperative PGD and infections persist but are expected to be addressed with continued efforts, gaining further experience, and infrastructure development," the article reads. The authors also acknowledged the contributions of Amitabha Chattopadhyay, Munna Das, Sanjiban Ghosh, Jayita Nandy Das, Manish Kumar Sharma, Rangan Koley, and Shivani Gajpal of Narayana Superspeciality Hospital, Howrah.

Centre approves 100-bed yoga and naturopathy hospital in Guntur
Centre approves 100-bed yoga and naturopathy hospital in Guntur

The Hindu

time6 hours ago

  • The Hindu

Centre approves 100-bed yoga and naturopathy hospital in Guntur

The Central government has approved the establishment of a 100-bed hospital under the Central Research Institute of Yoga and Naturopathy (CRIYN) at Nadimpalem village in Prathipadu mandal of Guntur district, with a total outlay of ₹94 crore. Union Minister of State for Rural Development and Communications, Dr. Pemmasani Chandra Sekhar, on Thursday informed that the hospital will be built on 15 acres under the Ministry of AYUSH and will be fully funded by the Centre. The hospital will include modern medical facilities, a scientific research centre, a training institute, and residential quarters for medical staff. The project aims to offer round-the-clock integrated healthcare services, blending traditional Indian medicine with scientific research. Minister Pemmasani said the centre would serve as a national hub for research, training, and treatment in yoga and naturopathy, contributing to healthier lifestyles through traditional practices. He termed it as a major opportunity not just for Guntur but for entire Andhra Pradesh. He expressed gratitude to Prime Minister Narendra Modi, Union Minister of State (Independent Charge) of the Ministry of Ayush Jadhav Prataprao Ganpatrao, and the Central government, highlighting that the project is a milestone in Andhra Pradesh's healthcare development under Chief Minister N. Chandrababu Naidu's leadership.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store